Would you consider definitive radiotherapy for IPMN in a patient who is not a surgical candidate?
Is there a benefit to EBRT/SBRT or would you choose observation until there is pathologic evidence of invasive pancreatic cancer?
Answer from: Radiation Oncologist at Academic Institution
This is an interesting question, but no I would not. It does seem like a good idea. However, the dose of and impact of definitive radiation in the setting is not defined because there are no published data. In general, treatment of any patient without invasive disease is problematic unless the pre-i...